Tags

Type your tag names separated by a space and hit enter

Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis.
Phytomedicine. 2007 Feb; 14(2-3):153-9.P

Abstract

OBJECTIVE

To critically assess the evidence of supplements containing Trifolium pratense (red clover) isoflavones in the reduction of hot flush frequency in menopausal women.

DATA SOURCES

Systematic literature searches were performed in (Medline (1951 - April 2006), Embase (1974 - April 2006), CINAHL (1982 - April 2006), Amed (1985 - April 2006) and The Cochrane Library (Issue 2, 2006). Reference lists located were checked for further relevant publications. Experts in the field and manufacturers of identified products were contacted for unpublished material. No language restrictions were imposed.

REVIEW METHODS

Studies were selected according to predefined inclusion and exclusion criteria. All randomized clinical trials of monopreparations containing T. pratense isoflavones for treating hot flushes were included. Study selection, data extraction and validation were performed by at least two reviewers with disagreements being settled by discussion. Weighted means and 95% confidence intervals were calculated and sensitivity analyses were performed.

RESULTS

Seventeen potentially relevant articles were retrieved for further evaluation. Five were suitable for inclusion in the meta-analysis. The meta-analysis indicates a reduction in hot flush frequency in the active treatment group (40-82 mg daily) compared with the placebo group (weighted mean difference -1.5 hot flushes daily; 95% CI -2.94 to 0.03; p=0.05).

CONCLUSION

There is evidence of a marginally significant effect of T. pratense isoflavones for treating hot flushes in menopausal women. Whether the size of this effect can be considered clinically relevant is unclear. Whereas there is no apparent evidence of adverse events during short-term use, there are no available data on the safety of long-term administration.

Authors+Show Affiliations

Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, 25 Victoria Park Road, Exeter EX2 4NT, UK.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Review
Systematic Review

Language

eng

PubMed ID

17239573

Citation

Coon, Joanna Thompson, et al. "Trifolium Pratense Isoflavones in the Treatment of Menopausal Hot Flushes: a Systematic Review and Meta-analysis." Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 14, no. 2-3, 2007, pp. 153-9.
Coon JT, Pittler MH, Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine. 2007;14(2-3):153-9.
Coon, J. T., Pittler, M. H., & Ernst, E. (2007). Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 14(2-3), 153-9.
Coon JT, Pittler MH, Ernst E. Trifolium Pratense Isoflavones in the Treatment of Menopausal Hot Flushes: a Systematic Review and Meta-analysis. Phytomedicine. 2007;14(2-3):153-9. PubMed PMID: 17239573.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. AU - Coon,Joanna Thompson, AU - Pittler,Max H, AU - Ernst,Edzard, Y1 - 2007/01/18/ PY - 2006/07/21/received PY - 2006/11/07/accepted PY - 2007/1/24/pubmed PY - 2007/4/11/medline PY - 2007/1/24/entrez SP - 153 EP - 9 JF - Phytomedicine : international journal of phytotherapy and phytopharmacology JO - Phytomedicine VL - 14 IS - 2-3 N2 - OBJECTIVE: To critically assess the evidence of supplements containing Trifolium pratense (red clover) isoflavones in the reduction of hot flush frequency in menopausal women. DATA SOURCES: Systematic literature searches were performed in (Medline (1951 - April 2006), Embase (1974 - April 2006), CINAHL (1982 - April 2006), Amed (1985 - April 2006) and The Cochrane Library (Issue 2, 2006). Reference lists located were checked for further relevant publications. Experts in the field and manufacturers of identified products were contacted for unpublished material. No language restrictions were imposed. REVIEW METHODS: Studies were selected according to predefined inclusion and exclusion criteria. All randomized clinical trials of monopreparations containing T. pratense isoflavones for treating hot flushes were included. Study selection, data extraction and validation were performed by at least two reviewers with disagreements being settled by discussion. Weighted means and 95% confidence intervals were calculated and sensitivity analyses were performed. RESULTS: Seventeen potentially relevant articles were retrieved for further evaluation. Five were suitable for inclusion in the meta-analysis. The meta-analysis indicates a reduction in hot flush frequency in the active treatment group (40-82 mg daily) compared with the placebo group (weighted mean difference -1.5 hot flushes daily; 95% CI -2.94 to 0.03; p=0.05). CONCLUSION: There is evidence of a marginally significant effect of T. pratense isoflavones for treating hot flushes in menopausal women. Whether the size of this effect can be considered clinically relevant is unclear. Whereas there is no apparent evidence of adverse events during short-term use, there are no available data on the safety of long-term administration. SN - 0944-7113 UR - https://www.unboundmedicine.com/medline/citation/17239573/Trifolium_pratense_isoflavones_in_the_treatment_of_menopausal_hot_flushes:_a_systematic_review_and_meta_analysis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0944-7113(06)00226-1 DB - PRIME DP - Unbound Medicine ER -